Gemayel Georges
Supernus Pharmaceuticals, Inc. · Director
Gemayel Georges is listed in public filings as director. This Gemayel Georges insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Supernus Pharmaceuticals, Inc. (SUPN), and Disc Medicine, Inc. (IRON). Investors use Gemayel Georges's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.4M27.3k shares | SellMar 6, 2026 | $465.7K8.8k shares | $53.00 | -- | |
| $07.9k shares | Grant / ExerciseMar 6, 2026 | $200.0K7.9k shares | $25.30 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.5M28.2k shares | SellMar 5, 2026 | $537.1K10k shares | $53.71 | -- | |
| --4.5k shares | OtherFeb 24, 2026 | Disclosure amount unavailable4.5k shares | -- | -- | |
| --38.2k shares | Grant / ExerciseFeb 24, 2026 | Disclosure amount unavailable4.5k shares | -- | -- | |
| $015k shares | Grant / ExerciseFeb 23, 2026 | $194.7K15k shares | $12.98 | -- | |
| $250k5k shares | Grant / ExerciseFeb 18, 2026 | $249.8K5k shares | $50.20 | -- | |
| --3k shares | Grant / ExerciseFeb 18, 2026 | Disclosure amount unavailable3k shares | -- | -- | |
| $60k1k shares | Grant / ExerciseSep 16, 2025 | $60.3K1k shares | $60.34 | -- | |
| $509k10k shares | Grant / ExerciseJun 11, 2025 | $508.6K10k shares | $50.86 | -- |